Le Lézard
Classified in: Science and technology
Subject: PDT

NopSec announces general availability of NopSec Unified VRM® in the CrowdStrike® Store


NEW YORK, Jan. 28, 2020 /PRNewswire-PRWeb/ -- NopSec today announced the availability of its leading enterprise Vulnerability Risk Management SaaS application, NopSec Unified VRM, in the CrowdStrike® Store. NopSec Unified VRM provides visibility and insight for customers to close security gaps for vulnerability remediation in real time. CrowdStrike endpoint data is ingested into NopSec Unified VRM platform, which provides holistic remediation visibility across infrastructures, endpoints and applications. By funneling contextual endpoint and network information into NopSec's platform, Unified VRM simulates and prioritizes which vulnerabilities could impact the overall IT environment and which security controls could be validated or bypassed in real-world attack scenarios. This contextual enrichment enables the security teams to better prioritize and proactively address potential threats in their infrastructure as well as perform contextual threat modeling and control validation on network and endpoints.

"CrowdStrike is very excited to have NopSec's Unified VRM solution available to CrowdStrike Falcon® platform customers via the CrowdStrike Store," said Andy Horwitz, Vice President of CrowdStrike Store. "The combination of Falcon Spotlighttm vulnerability data, with NopSec's vulnerability prioritization creates real-time visibility and prescriptive remediation actions that provide a unique value to our customers."

"The sheer volume of vulnerabilities makes it impossible to patch everything. NopSec Unified VRM provides customers holistic visibility of vulnerability intelligence across infrastructure and endpoints by incorporating CrowdStrike endpoint data, and enables customers to prioritize remediation efforts based on risk and business contexts." said Lisa Xu, Chief Executive Officer of NopSec. "We are excited about what Unified VRM and Falcon Spotlight can bring to the market, and providing customers the world-class vulnerability management program intelligence to stay ahead of the cyber threats."

NopSec Unified VRM is available for trial in the CrowdStrike Store for Falcon platform customers. CrowdStrike and NopSec will be hosting a joint webinar to showcase the value of the combination of the two powerful solutions on January 29, 2020.
Visit here for more details: https://go.crowdstrike.com/NWB_CS_NopSec_CrowdStrike_Store_HowTo_VRM.html

About NopSec
NopSec, a leader in Vulnerability Risk Management, provides ML-based threat prediction and cyber risk remediation solutions to make cyber data humanly digestible and reduce time to remediation. The company is based in New York City. http://www.nopsec.com

 

SOURCE NopSec


These press releases may also interest you

at 14:33
Enabled Intelligence (EI), a global leader in mission-critical AI data solutions for the US Defense and Intelligence Community today announced a groundbreaking new partnership with Melwood, a leading employer, advocate, and service provider for...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
Transflo, a leading provider of technology solutions for the transportation industry, is thrilled to announce that it has won three 2024 Top Workplaces Culture Excellence awards. The honors are awarded by Energage, a purpose-driven organization that...

at 14:05
Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today published its 2024 Cyber Claims Report, which details emerging cyber trends and their impact on Coalition policyholders throughout 2023....

at 14:04
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...



News published on and distributed by: